List of Tables
Number of Products under Development for Human Immunodeficiency Virus (HIV) Infections (AIDS), H2 2016 57
Number of Products under Development for Human Immunodeficiency Virus (HIV) Infections (AIDS) – Comparative Analysis, H2 2016 58
Number of Products under Development by Companies, H2 2016 60
Number of Products under Development by Companies, H2 2016 (Contd..1) 61
Number of Products under Development by Companies, H2 2016 (Contd..2) 62
Number of Products under Development by Companies, H2 2016 (Contd..3) 63
Number of Products under Development by Companies, H2 2016 (Contd..4) 64
Number of Products under Development by Companies, H2 2016 (Contd..5) 65
Number of Products under Development by Companies, H2 2016 (Contd..6) 66
Number of Products under Development by Companies, H2 2016 (Contd..7) 67
Number of Products under Development by Companies, H2 2016 (Contd..8) 68
Number of Products under Development by Companies, H2 2016 (Contd..9) 69
Number of Products under Development by Companies, H2 2016 (Contd..10) 70
Number of Products under Development by Companies, H2 2016 (Contd..11) 71
Number of Products under Investigation by Universities/Institutes, H2 2016 72
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 73
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 74
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..3) 75
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..4) 76
Number of Products under Investigation by Universities/Institutes, H2 2016 (Contd..5) 77
Comparative Analysis by Late Stage Development, H2 2016 78
Comparative Analysis by Clinical Stage Development, H2 2016 79
Comparative Analysis by Early Stage Development, H2 2016 80
Comparative Analysis by Unknown Stage Development, H2 2016 81
Products under Development by Companies, H2 2016 82
Products under Development by Companies, H2 2016 (Contd..1) 83
Products under Development by Companies, H2 2016 (Contd..2) 84
Products under Development by Companies, H2 2016 (Contd..3) 85
Products under Development by Companies, H2 2016 (Contd..4) 86
Products under Development by Companies, H2 2016 (Contd..5) 87
Products under Development by Companies, H2 2016 (Contd..6) 88
Products under Development by Companies, H2 2016 (Contd..7) 89
Products under Development by Companies, H2 2016 (Contd..8) 90
Products under Development by Companies, H2 2016 (Contd..9) 91
Products under Development by Companies, H2 2016 (Contd..10) 92
Products under Development by Companies, H2 2016 (Contd..11) 93
Products under Development by Companies, H2 2016 (Contd..12) 94
Products under Development by Companies, H2 2016 (Contd..13) 95
Products under Development by Companies, H2 2016 (Contd..14) 96
Products under Development by Companies, H2 2016 (Contd..15) 97
Products under Development by Companies, H2 2016 (Contd..16) 98
Products under Development by Companies, H2 2016 (Contd..17) 99
Products under Development by Companies, H2 2016 (Contd..18) 100
Products under Development by Companies, H2 2016 (Contd..19) 101
Products under Investigation by Universities/Institutes, H2 2016 102
Products under Investigation by Universities/Institutes, H2 2016 (Contd..1) 103
Products under Investigation by Universities/Institutes, H2 2016 (Contd..2) 104
Products under Investigation by Universities/Institutes, H2 2016 (Contd..3) 105
Products under Investigation by Universities/Institutes, H2 2016 (Contd..4) 106
Products under Investigation by Universities/Institutes, H2 2016 (Contd..5) 107
Products under Investigation by Universities/Institutes, H2 2016 (Contd..6) 108
Products under Investigation by Universities/Institutes, H2 2016 (Contd..7) 109
Products under Investigation by Universities/Institutes, H2 2016 (Contd..8) 110
Products under Investigation by Universities/Institutes, H2 2016 (Contd..9) 111
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Abivax SA, H2 2016 112
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by AdAlta Ltd, H2 2016 113
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Advanced Genetic Systems Inc, H2 2016 114
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Akshaya Bio Inc, H2 2016 115
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by AlbaJuna Therapeutics, H2 2016 116
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Allergan Plc, H2 2016 117
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Altor BioScience Corp, H2 2016 118
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Altravax Inc, H2 2016 119
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Amarna Therapeutics BV, H2 2016 120
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by American Gene Technologies International Inc, H2 2016 121
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Amunix Operating Inc, H2 2016 122
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Antigen Express Inc, H2 2016 123
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Aphios Corp, H2 2016 124
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Apotex Inc, H2 2016 125
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Argos Therapeutics Inc, H2 2016 126
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Arno Therapeutics Inc, H2 2016 127
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Atreca Inc, H2 2016 128
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by B Cell Design SAS, H2 2016 129
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by BioClonetics Immunotherapeutics Inc, H2 2016 130
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Biological Mimetics Inc, H2 2016 131
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Biosantech SA, H2 2016 132
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Biotron Ltd, H2 2016 133
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Boehringer Ingelheim GmbH, H2 2016 134
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Bolder Biotechnology Inc, H2 2016 135
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Bristol-Myers Squibb Company, H2 2016 136
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by C4X Discovery Holdings PLC, H2 2016 137
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Calimmune Inc, H2 2016 138
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by CEL-SCI Corp, H2 2016 139
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Celgene Corp, H2 2016 140
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Celldex Therapeutics Inc, H2 2016 141
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Chipscreen Biosciences Ltd, H2 2016 142
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by CompleGen Inc, H2 2016 143
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ConjuChem LLC, H2 2016 144
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ContraVir Pharmaceuticals Inc, H2 2016 145
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Critical Outcome Technologies Inc, H2 2016 146
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Curevac AG, H2 2016 147
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Cytodyn Inc, H2 2016 148
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Dong-A Socio Holdings Co Ltd, H2 2016 149
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Enzo Biochem Inc, H2 2016 150
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by EpiVax Inc, H2 2016 151
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by eTheRNA Immunotherapies NV, H2 2016 152
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Etubics Corp, H2 2016 153
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Evofem Inc, H2 2016 154
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by FIT Biotech Oy, H2 2016 155
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Formune SL, H2 2016 156
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Fountain Biopharma Inc, H2 2016 157
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Frontier Biotechnologies Co Ltd, H2 2016 158
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Galmed Pharmaceuticals Ltd, H2 2016 159
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GeneCure LLC, H2 2016 160
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GeoVax Labs Inc, H2 2016 161
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Gilead Sciences Inc, H2 2016 162
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GlaxoSmithKline Plc, H2 2016 163
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Globeimmune Inc, H2 2016 164
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by GW Pharmaceuticals Plc, H2 2016 165
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by H-Phar SA, H2 2016 166
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Hadasit Medical Research Services & Development Ltd, H2 2016 167
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Hanmi Pharmaceuticals Co Ltd, H2 2016 168
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Heat Biologics Inc, H2 2016 169
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ID Pharma Co Ltd, H2 2016 170
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by IGXBio Inc, H2 2016 171
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immune Response BioPharma Inc, H2 2016 172
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immune Therapeutics Inc, H2 2016 173
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ImmunoClin Corp, H2 2016 174
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immunocore Ltd, H2 2016 175
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Immunotope Inc, H2 2016 176
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ImQuest Life Sciences Inc, H2 2016 177
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by InnaVirVax SA, H2 2016 178
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Innovative Targeting Solutions Inc, H2 2016 179
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Inovio Pharmaceuticals Inc, H2 2016 180
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Japan Tobacco Inc, H2 2016 181
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Johnson & Johnson, H2 2016 182
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Karyopharm Therapeutics Inc, H2 2016 183
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by KPI Therapeutics Inc, H2 2016 184
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Kymab Ltd, H2 2016 185
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Longevity Biotech Inc, H2 2016 186
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by MacroGenics Inc, H2 2016 187
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Medestea Research & Production SpA, H2 2016 188
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Medivir AB, H2 2016 189
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Merck & Co Inc, H2 2016 190
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Mologen AG, H2 2016 191
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Mymetics Corp, H2 2016 192
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Myrexis Inc, H2 2016 193
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by NanoViricides Inc, H2 2016 194
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Navigen Pharmaceuticals Inc, H2 2016 195
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by NeED Pharma srl, H2 2016 196
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by New World Laboratories Inc, H2 2016 197
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Novartis AG, H2 2016 198
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Omeros Corp, H2 2016 199
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Oncolys BioPharma Inc, H2 2016 200
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by OncoNOx ApS, H2 2016 201
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Oncovir Inc, H2 2016 202
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Orbis Biosciences Inc, H2 2016 203
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Osel Inc, H2 2016 204
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by OyaGen Inc, H2 2016 205
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by PaxVax Inc, H2 2016 206
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Peregrine Pharmaceuticals Inc, H2 2016 207
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Pfizer Inc, H2 2016 208
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Pharis Biotec GmbH, H2 2016 209
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by PharmatrophiX Inc, H2 2016 210
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Phoenix Biotechnology Inc, H2 2016 211
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by PlantForm Corp, H2 2016 212
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Profectus BioSciences Inc, H2 2016 213
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by RAPID Pharmaceuticals AG, H2 2016 214
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ReceptoPharm Inc, H2 2016 215
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Recombio SL, H2 2016 216
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Relmada Therapeutics Inc, H2 2016 217
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Rodos BioTarget GmbH, H2 2016 218
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Samjin Pharmaceutical Co Ltd, H2 2016 219
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sangamo BioSciences Inc, H2 2016 220
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sanofi, H2 2016 221
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sanofi Pasteur SA, H2 2016 222
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Savoy Pharmaceuticals Inc, H2 2016 223
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Serometrix LLC, H2 2016 224
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sigma-Tau SpA, H2 2016 225
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sirenas Marine Discovery LLC, H2 2016 226
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Solon Eiendom ASA, H2 2016 227
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Spider Biotech, H2 2016 228
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Spring Bank Pharmaceuticals Inc, H2 2016 229
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Staidson (Beijing) Biopharmaceuticals Co Ltd, H2 2016 230
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Starpharma Holdings Ltd, H2 2016 231
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Sumagen Co Ltd, H2 2016 232
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Susavion Biosciences Inc, H2 2016 233
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Taiga Biotechnologies Inc, H2 2016 234
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by TaiMed Biologics Inc, H2 2016 235
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Takara Bio Inc, H2 2016 236
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Takeda Pharmaceutical Company Ltd, H2 2016 237
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by TechnoVax Inc, H2 2016 238
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by TeneoBio Inc, H2 2016 239
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by TetraLogic Pharmaceuticals, H2 2016 240
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Teva Pharmaceutical Industries Ltd, H2 2016 241
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by TGV-Laboratories, H2 2016 242
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Theratechnologies Inc, H2 2016 243
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Theravectys SA, H2 2016 244
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Tomegavax Inc, H2 2016 245
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Transgene Biotek Ltd, H2 2016 246
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by TVAX Biomedical Inc, H2 2016 247
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by United Biomedical Inc, H2 2016 248
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Vaccibody AS, H2 2016 249
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Vault Pharma Inc, H2 2016 250
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by VDA Pharma Inc, H2 2016 251
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by VG Life Sciences Inc, H2 2016 252
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Vichem Chemie Research Ltd, H2 2016 253
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ViiV Healthcare Ltd, H2 2016 254
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Viriom Ltd, H2 2016 255
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by ViroStatics srl, H2 2016 256
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by XL-protein GmbH, H2 2016 257
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Pipeline by Zydus Cadila Healthcare Ltd, H2 2016 258
Assessment by Monotherapy Products, H2 2016 259
Assessment by Combination Products, H2 2016 260
Number of Products by Stage and Target, H2 2016 262
Number of Products by Stage and Mechanism of Action, H2 2016 274
Number of Products by Stage and Route of Administration, H2 2016 286
Number of Products by Stage and Molecule Type, H2 2016 288
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects, H2 2016 909
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..1), H2 2016 910
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..2), H2 2016 911
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..3), H2 2016 912
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..4), H2 2016 913
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..5), H2 2016 914
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..6), H2 2016 915
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..7), H2 2016 916
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..8), H2 2016 917
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..9), H2 2016 918
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..10), H2 2016 919
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..11), H2 2016 920
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..12), H2 2016 921
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..13), H2 2016 922
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..14), H2 2016 923
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..15), H2 2016 924
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..16), H2 2016 925
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..17), H2 2016 926
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..18), H2 2016 927
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..19), H2 2016 928
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..20), H2 2016 929
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..21), H2 2016 930
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..22), H2 2016 931
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..23), H2 2016 932
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..24), H2 2016 933
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..25), H2 2016 934
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..26), H2 2016 935
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..27), H2 2016 936
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..28), H2 2016 937
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..29), H2 2016 938
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..30), H2 2016 939
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..31), H2 2016 940
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..32), H2 2016 941
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..33), H2 2016 942
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..34), H2 2016 943
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..35), H2 2016 944
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..36), H2 2016 945
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..37), H2 2016 946
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..38), H2 2016 947
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..39), H2 2016 948
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..40), H2 2016 949
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..41), H2 2016 950
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..42), H2 2016 951
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..43), H2 2016 952
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..44), H2 2016 953
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..45), H2 2016 954
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..46), H2 2016 955
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Dormant Projects (Contd..47), H2 2016 956
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products, H2 2016 957
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products (Contd..1), H2 2016 958
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products (Contd..2), H2 2016 959
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products (Contd..3), H2 2016 960
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products (Contd..4), H2 2016 961
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products (Contd..5), H2 2016 962
Human Immunodeficiency Virus (HIV) Infections (AIDS) – Discontinued Products (Contd..6), H2 2016 9